electronic data capture

empowering clinical research

frictionless data capture empowering your research

Capture data & engage patients with next generational clinical research tools. Find out how we can empower your clinical research.

 

research banner.png

 enhance your research through rich data sets

Our solutions capture rich objective data from sensors & devices as well as data from Patient Reported Outcome (PRO) Surveys and Geo-medicine (e.g. air quality).

 
spirometry

Spirometry

 
blood pressure new.png

Blood Pressure

 
completedSurveyIcon@3x.png

Patient Reported Outcome (PRO) Surveys

 
weightIcon@2x.png

Weight

 
airQuality4@2x.png

Geo-medicine (e.g. air quality)

 
oxegenIcon@2x.png

Oximetry

 

Our multifaceted digital biobank extends our utility over a number of fields, with customers across oncology, pulmonary, nephrology and heart failure.

 
digital biobank.png
glenda (1).png
 

 

solutions+banner.jpg

our credentials

 We have extensive experience with ethics, security & compliance. We are approved by the IRB and ethics and IT security departments at leading hospitals in the US, UK, and Ireland.

 

our current customers

We work with some of the leading hospitals and medical institutions in the US, UK, and Ireland.

nottingham nhs.gif
ipcor-logo.jpg
 
port-1478685086.jpg
 
GUH logo Dec 2015_0.jpg
 
mater hospital.png
 

patient focused solutions

We work with leading patient organizations and ensure our solutions work for people of all ages, with high engagement & retention.

EU-IPFF_Logo-RGB.png
www.ilfa_.ie_.jpg
logo-hort.png
ipf italian.png
pftrust.png
pfwarriors.png

 

data+banner.jpg

our study experience

 

RCTs

addAppointmentIcon@2x.png

We have completed two Randomized Control Trials analysing the effectiveness of our solutions in association with the Department of Respiratory Medicine, Galway, Ireland and the Renal Dialysis Centre Beaumont Hospital, Dublin, Ireland, respectively.

 

We are currently working with Vanderbilt University Medical Center on a clinical trial proposing ‘that structured telenursing can increase quality of life for IPF patients.’

vanderbilt.jpg
 

observational studies

diaryIcon@2x.png

We are currently running an observational study in association with the Department of Respiratory Medicine, Dublin, Ireland to, among other objectives,  assess the acceptability and utility of the patientMpower app in helping IPF patients and their healthcare professional caregivers manage their condition.  

Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis

 

We recently completed a study with Nottingham University Hospital identifying biomarkers of progressive fibrotic lung disease.

nottingham nhs.gif
 

ATS Publications

At ATS 2018, we presented two publications of observational studies related to IPF.

we will be presenting three new publications at ATS 2019

‘Longitudinal trends in air quality and home-recorded spirometry in pulmonary fibrosis patients in the Dallas-Fort Worth area’

‘Use of a mobile application (patientMpower) to capture longitudinal data on air quality and home spirometry in United States based pulmonary fibrosis patients’

‘Real-world usage of a mobile electronic health journal (patientMpower) for pulmonary fibrosis in a US patient support group (PF Warriors) over 12 months’

 

real world evidence

genericProfileIcon.png

We conducted a study with the PF Warriors Support Group on the utility and acceptability of patientMpower. These were the results:

100%.png
‘Using patientMpower had a positive effect on my well-being & daily life.’.png
‘I want to continue using patientMpower after the survey.’  .png
‘I would recommend other people with my condition to use patientMpower.’.png
 

frictionless data capture empowering your research

Capture data & engage patients with next generational clinical research tools. Find out how we can empower your clinical research.

 

partner with us banner.png

partner with us

If you are a healthcare professional or dialysis provider interested in joining our clinical trial programme or commercial pilots, please contact us.

If you are a potential investor, please contact us.